Associate VP, Risk Management
United Therapeutics Corporation
Summary
The Associate Vice President, Risk Management (RM) establishes, operationalizes, and manages UT's corporate level risk, insurance and business continuity programs, including Enterprise Risk Management (ERM), Organizational Resiliency (OR), and risk transfer insurance programs.
Job description
- Manage a corporate-wide insurance program (currently >100 individual insurance policies) to protect our business against operational risks such as theft, financial losses, employees' health and accidents, among other insurable risks. This responsibility includes managing all broker and insurer relationships
- Operationalize and manage UT's Enterprise Risk Management (ERM) program to identify business and operational risks and then analyze, classify, and assisting the business functional leaders to manage risks and exposures that would prevent UT from reaching its strategic objectives
- Manage and coordinate UT's Organizational Resiliency (OR) program, and including business continuity plans to help business functions (critical and/or otherwise) continue operations during disruptive events
- Provide consultation as well as technical insurance & risk advice with respect to insurance and other risk management considerations across UT, including the corporate legal department, the corporate and business development initiatives, and various functional business leaders
- Manage various risk and insurance related activities, including the maintenance of a Risk Management Manual; identify and analyze UT's supply chain risk for management needs and vulnerability exposures; oversee and maintain certificate insurance requirements and records; among other responsibilities and activities
- Inspire, mentor, manage and motivate staff to enhance business and financial knowledge through experience, internal exposure, collaboration, leadership and technical development and learning
- Performs all other duties as assigned
Requirements
- Bachelor's Degree and 15+ years in insurance and/or risk management field
- Advanced knowledge of Enterprise Risk Management principles and practices
- Advanced knowledge of organizational resilience and business continuity practices
- Extensive experience with commercial insurance programs, coverage analysis, and negotiation
- Extensive experience negotiating contractual risk provisions, including indemnification language
- Experience leading safety, loss prevention, and claims management programs
- Demonstrated ability to identify and lead significant organizational change
- Ability to influence senior leaders and key stakeholders across the organization
- Ability to communicate complex information effectively to executive and cross-functional audiences
- Advanced analytical and quantitative problem-solving skills
- Experience developing and presenting risk analyses, recommendations, and executive-level reporting
- Demonstrated ability to exercise independent judgment on complex and high-impact matters
- Experience operating effectively within a large, complex organization
- Strong organizational skills with the ability to manage multiple high-priority initiatives
- Proficiency in Microsoft Word and Excel
Benefits
- Medical, Dental & Vision
- Prescription Coverage
- Employee Wellness Resources
- 401(k)
- Employee Stock Purchase Plan
- Paid Time Off
- Paid Parental Leave
- Disability Benefits
Company overview
United Therapeutics Corporation is an American biotechnology company founded in 1996 with a deeply personal mission: to find a cure for pulmonary arterial hypertension (PAH) after the founder's daughter was diagnosed with this rare disease. Headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, the company has evolved into a pioneering force in biotechnology, focusing on developing novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. United Therapeutics specializes in treatments for pulmonary arterial hypertension, pulmonary hypertension associated with interstitial lung disease, neuroblastoma, and end-stage lung disease through its flagship products including Tyvaso, Remodulin, Orenitram, Adcirca, and Unituxin. The company is particularly notable for being the first publicly-traded biotech or pharmaceutical company to convert to a public benefit corporation (PBC), with a dual purpose of developing innovative pharmaceutical therapies and creating technologies that increase transplantable organ availability. Their groundbreaking work includes xenotransplantation research, organ manufacturing technologies, and regenerative medicine programs aimed at addressing critical shortages in transplantable organs. With approximately 1,001-5,000 employees and a strong commitment to corporate social responsibility, United Therapeutics has established itself as a leader in both patient-focused innovation and workplace excellence.